These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30272867)

  • 21. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations: long-term follow-up results.
    Weitz-Tuoretmaa A; Rautio R; Valkila J; Keski-Säntti H; Keski-Nisula L; Laranne J
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):385-90. PubMed ID: 23649509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant pediatric cervicofacial lymphatic malformations.
    Benazzou S; Boulaadas M; Essakalli L
    J Craniofac Surg; 2013 Jul; 24(4):1307-9. PubMed ID: 23851794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
    Ghaffarpour N; Petrini B; Svensson LA; Boman K; Wester T; Claesson G
    Acta Paediatr; 2015 Nov; 104(11):1169-73. PubMed ID: 26081020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
    Mathur NN; Rana I; Bothra R; Dhawan R; Kathuria G; Pradhan T
    Int J Pediatr Otorhinolaryngol; 2005 Jan; 69(1):75-80. PubMed ID: 15627451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic Malformation Architecture: Implications for Treatment With OK-432.
    Malic CC; Guilfoyle R; Courtemanche RJM; Arneja JS; Heran MKS; Courtemanche DJ
    J Craniofac Surg; 2017 Oct; 28(7):1721-1724. PubMed ID: 28834841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerotherapy of lymphangiomas of the head and neck.
    Wiegand S; Eivazi B; Zimmermann AP; Sesterhenn AM; Werner JA
    Head Neck; 2011 Nov; 33(11):1649-55. PubMed ID: 20737487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multistage Sclerotherapy for Extensive Lymphatic Malformations With Airway Involvement in Infant: A Protocol to Prevent Tracheotomy.
    Chen AW; Wang T; Huang YY; Liu SH
    J Oral Maxillofac Surg; 2017 Sep; 75(9):1882-1890. PubMed ID: 28390757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children.
    Wiegand S; Wichmann G; Dietz A; Werner JA
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2535-2540. PubMed ID: 36695910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time MRI-guided percutaneous sclerotherapy of low-flow head and neck lymphatic malformations in the pediatric population - a stepwise approach.
    Partovi S; Vidal L; Lu Z; Nakamoto DA; Buethe J; Clampitt M; Coffey M; Patel IJ
    Pediatr Radiol; 2017 May; 47(6):755-760. PubMed ID: 28213627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in lymphatic malformation.
    Lee BB; Kim YW; Seo JM; Hwang JH; Do YS; Kim DI; Byun HS; Lee SK; Huh SH; Hyun WS
    Vasc Endovascular Surg; 2005; 39(1):67-81. PubMed ID: 15696250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy.
    Greinwald JH; Burke DK; Sato Y; Poust RI; Kimura K; Bauman NM; Smith RJ
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):381-7. PubMed ID: 10504592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant lymphangioma of the tongue.
    Hong JP; Lee MY; Kim EK; Seo DH
    J Craniofac Surg; 2009 Jan; 20(1):252-4. PubMed ID: 19165040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative adjuvant OK-432 sclerotherapy for treatment of cervicofacial lymphatic malformations: an outcomes comparison.
    Kim SY; Lee S; Seo JM; Lim SY
    Int J Pediatr Otorhinolaryngol; 2015 Apr; 79(4):570-5. PubMed ID: 25698461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative volumetric analysis of head and neck venous and lymphatic malformations to assess response to percutaneous sclerotherapy.
    Alexander MD; McTaggart RA; Choudhri OA; Pandit RP; Wu A; Ross M; Do HM
    Acta Radiol; 2016 Feb; 57(2):205-9. PubMed ID: 25788316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerosing agents in the management of lymphatic malformations in children: A systematic review.
    Fernandes S; Yeung P; Heran M; Courtemanche D; Chadha N; Baird R
    J Pediatr Surg; 2022 May; 57(5):888-896. PubMed ID: 35151497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.
    Shergill A; John P; Amaral JG
    Pediatr Radiol; 2012 Sep; 42(9):1080-8. PubMed ID: 22648390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin sclerotherapy in lymphangiomas of the head and neck region: a prospective study.
    Tiwari P; Pandey V; Bera RN; Sharma SP; Chauhan N
    Int J Oral Maxillofac Surg; 2021 May; 50(5):619-626. PubMed ID: 33059994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response.
    Närkiö-Mäkelä M; Mäkelä T; Saarinen P; Salminen P; Julkunen I; Pitkäranta A
    Eur Arch Otorhinolaryngol; 2011 Jan; 268(1):123-9. PubMed ID: 20635092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.